Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Premarin Stories

2014-03-13 17:07:09

When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers. The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol — the dominant...

2013-11-19 23:19:48

NutraPause is a botanical supplement clinically shown to relieve vasomotor symptoms (hot flashes and night sweats) associated with perimenopause and menopause. Toronto, Canada (PRWEB) November 19, 2013 AC Nova Technologies Inc (aka ATI Pharma), a leader in the development of evidence-based botanical supplements, is pleased to announce that Health Canada has approved NutraPause for the treatment of vasomotor symptoms associated with perimenopause and menopause (NPH 80031417). ATI Pharma...

2013-10-02 10:22:32

Extended follow-up of the two Women's Health Initiative hormone therapy trials does not support use of hormones for chronic disease prevention, although the treatment may be appropriate for menopausal symptom management in some women, according to a study in the October 2 issue of JAMA. The hormone therapy trials of the Women's Health Initiative (WHI) were stopped after investigators found that the health risks outweighed the benefits. Menopausal hormone therapy continues in clinical use,...

2013-10-01 13:44:03

The oral hormone therapy conjugated equine estrogens (CEEs), which is used by women to relieve menopause symptoms, appears to be associated with increased risk for venous thrombosis (VT, blood clots) and possibly myocardial infarction (heart attack), but not ischemic stroke risk, when compared with the hormone therapy oral estradiol, according to a study published by JAMA Internal Medicine, a JAMA Network publication. Researchers compared the cardiovascular safety of the two commonly used...

2013-10-01 13:42:41

JAMA Internal Medicine publishes University of Washington -- Group Health study Women can choose among several types of estrogen pills, which are equally effective at relieving menopausal symptoms. But in an observational study of comparative safety, use of estradiol was associated with less risk of developing blood clots in leg veins (deep vein thrombosis) and clots in the lungs (pulmonary emboli) than was use of conjugated equine estrogens. According to a joint University of Washington...

2013-05-08 08:30:39

PRINCETON, N.J., May 8, 2013 /PRNewswire/ -- Novo Nordisk announced that a new survey of women on local estrogen therapy revealing key insights into reasons for treatment non-compliance was published in the International Journal of Women's Health. The study, "Improved Compliance and Patient Satisfaction with Estradiol Vaginal Tablets in Postmenopausal Women Previously Treated with Another Local Estrogen Therapy," offers insight into reasons that various treatment regimens for vaginal atrophy...

2013-02-26 16:26:53

FLORHAM PARK, N.J., Feb. 26, 2013 /PRNewswire/ -- Shionogi Inc., the United States (U.S.)-based company of Shionogi & Co., Ltd., today announced that the U.S. Food and Drug Administration (FDA) has approved Osphena(TM) (ospemifene) tablets for the treatment of moderate to severe dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Osphena(TM), as an estrogen agonist/antagonist with tissue selective effects, is the first and only oral...

2012-11-08 12:28:08

DALLAS, Nov. 8, 2012 /PRNewswire/ -- For eight decades subcutaneous hormone pellet therapy has been utilized in patients. Currently hormone pellet therapy is used to treat peri-menopause, menopause, and andropause patients in five continents. The safety and efficacy of both estrogen and testosterone pellet therapy has been documented throughout the world's peer reviewed journals. In 2002, the initial data from the Women's Health Initiative (WHI) revealed an increased risk of breast cancer,...

2012-10-16 11:26:18

SAN DIEGO, Oct. 16, 2012 /PRNewswire-USNewswire/ -- The following is being issued by the law firms of Beasley Allen, P.C., Gary Holt & Associates, P.A., and Rushall & McGeever: Official notice to potential Class Members has begun in a class action lawsuit that claims that drug manufacturer Wyeth violated California laws by misrepresenting the benefits and/or failing to disclose the risks of the prescription hormone replacement therapy (HRT) medications Premarin, Prempro, and...

2012-10-03 10:24:14

Kronos Early Estrogen Prevention Study results to help clinicians assess HT risk-benefits PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Kronos Longevity Research Institute (KLRI) today announced that a major finding of the Kronos Early Estrogen Prevention Study (KEEPS) indicates that hormone therapy (HT) improves symptoms of depression and anxiety in recently menopausal women, without adverse effects on cognition. The findings come as a result of a four-year randomized clinical trial...